Oppé, T.E.: Infantile hypercalcemia, nutritional rickets, and infantile scurvy in Great Britain; a British Paediatric Association report. Brit. Med. J.1: 1659, 1964.
2.
Editorial: Vitamin D as a public health problem. Ibid.1: 1654, 1964 .
3.
Editorial: Aetiology of idiopathic hypercalcemia. Ibid. 1: 335, 1960.
4.
Editorial: Idiopathic hypercalcaemia of infants. Lancet2: 138, 1960.
Lightwood, R. , Sheldon, W., Harris, C. and Stapleton, T.: Hypercalcaemia in infants; subcommittee report, British Paediatric Association report. Lancet271: 136, 1956.
7.
—, —, — and —: Hypercalcaemia in infants and vitamin D; subcommittee report, British Paediatric Association report . Brit. Med. J.2: 149, 1956.
8.
Committee on Nutrition, American Academy of Pediatrics: Vitamin D intake and the hypercalcemic syndrome . Pediatrics35: 1022, 1965.
9.
Bakwin, H.: The overuse of vitamins in children. J. Pediat.59: 154, 1961.
10.
Committee on Nutrition, American Academy of Pediatrics: The relation between infantile hypercalcemia and vitamin D; public health implications in North America. (Report written by Fraser, D.) Pediatrics40: 1050, 1967.
11.
—: The prophylactic requirement and the toxicity of vitamin D. Ibid. 31: 512, 1963.
12.
Black, J.A.: Idiopathic hypercalcaemia and vitamin D. German Med. Monthly9: 290, 1964.
13.
Fraser, D., Kidd, B.S.L., Kooh, S.W. and Paunier, L.: A new look at infantile hypercalcemia. Pediat. Clin. N. Amer.13: 503, 1966.
14.
Seelig, M.S.: Vitamin D and cardiovascular, renal, and brain damage in infancy and childhood . Ann. N. Y. Acad. Sci.147: 537, 1969.
15.
Bing, F.C.: Vitamin D milk containing 600 USP units of vitamin D to the quart is not eligible for list of accepted foods. JAMA116: 413, 1941 .
16.
Harris, R.S. , Ross, B.D. and Bunker, J.W.M.: Histological study of hypervitaminosis D. Amer. J. Dig. Dis.6: 81, 1939.
17.
Morgan, A.F. , Kimmel, L. and Hawkins, N.C.: A comparison of the hypervitaminoses induced by irradiated ergosterol and fish liver oil concentrates. J. Biol. Chem.120: 85, 1937.
18.
Lewis, J.M. : Clinical experience with crystalline vitamin D; the influence of the menstruum on the effectiveness of the antirachitic factor. J. Pediat.6: 362, 1935.
19.
Stearns, G. , Jeans, P.C. and Vandecar, V.: The effect of vitamin D on linear growth in infancy. Ibid.9: 1, 1936.
20.
Drake, T.G.H. : Comparison of the antirachitic effects on human beings of vitamin D from different sources. Amer. J. Dis. Child.53: 754, 1937.
21.
Lewis, J.M. : Further observations on the comparative antirachitic value of crystalline vitamin D administered in milk, corn oil, or in propylene glycol. J. Pediat.8: 308, 1936.
22.
Glaser, K., Parmelee, A.H. and Hoffman, W.S.: Comparative efficacy of vitamin D preparations in prophylactic treatment of premature infants. Amer. J. Dis. Child.77: 1, 1949.
23.
Supplee, G.C. , Ansbacher, S., Bender, R.C. and Flanigan, G.E.: The influence of milk constituents on the effectiveness of vitamin D. J. Biol. Chem.114: 97, 1936.
24.
Loomis, W.F. : Skin-pigment regulation of vitamin D biosynthesis in man. Science157: 501, 1967.
25.
Wickel, K.G. : Theory and practice of vitamin D fortification of milk. Quart. Rev. Pediat.8: 224, 1953.
26.
Spur, B.: Laboratory evaluation and control of homogenized and vitamin D milk. Ibid. p. 240.
27.
Council on Foods and Nutrition: Fortification of nonfat milk solids with vitamins A and D. JAMA197: 1107,1966.
28.
Dale, A.E. and Lowenberg, M.E.: Consumption of vitamin D in fortified and natural foods and in vitamin preparations , J. Pediat.70: 952, 1967.
29.
Blunt, J.W. , De Luca H.F. andSchnoes H.K.25-hydroxycholecalciferol; a biologically active metabolite of vitamin D. Biochem.7: 3317, 1968.
30.
Avioli, L.V. , Williams, T.F., Lund, J. and De Luca, H.F.: Metabolism of vitamin D3-3H in vitamin D-resistant rickets and familial hypophosphatemia. J. Clin. Invest.46: 1907, 1967.
31.
Taussig, H.B. : Possible injury to the cardiovascular system from vitamin D. Ann. Intern. Med.65: 1195, 1966 .
32.
—: On the evolution of our knowledge of congenital malformations of the heart. Circulation31: 768, 1965.
33.
Norman, A.W. : The mode of action of vitamin D. Biol. Rev.43: 97, 1968.
34.
Rowe, R.D. and Cooke, R.E.: Vitamin D and craniofacial and dental anomalies of supravalvular stenosis . Pediatrics43: 1, 1969.
35.
Garcia, R.E. , Friedman, W.F., Kaback, M.M. and Rowe, R.D.: Idiopathic hypercalcemia and supravalvular aortic stenosis. New Eng. J. Med.271: 117, 1964 .
36.
Jue, K.L., Noren, G.R. and Anderson, R.C.: The syndrome of idiopathic hypercalcemia of infancy with associated congenital heart disease. J. Pediat.67: 1130, 1965.
37.
Friedman, W.F. and Roberts, W.C.: Vitamin D and the supravalvular aortic stenosis syndrome; the transplacental effects of vitamin D on the aorta of the rabbit. Circulation34: 77, 1966.
38.
Stapleton, T., Macdonald, W.B. and Lightwood , R.: Management of "idiopathic" hypercalcaemia in infancy. Lancet1: 932, 1956.
39.
Schllesinger, B.E., Butler, N.R. and Black, J.A.: Severe type of infantile hypercalcaemia . Brit. Med. J.1: 127, 1956.
40.
Wiltse, H.E. , Goldbloom, R.B., Antia, A.U., Ottesen, O.E., Rowe, R.D. and Cooke, R.E.: Infantile hypercalcemia syndrome in twins . New Eng. J. Med.275: 1157, 1966.
Barr, D.G.D. and Forfar, J.O.: Oral calcium-loading test in infancy, with particular reference to idiopathic hypercalcaemia. Brit. Med. J.1: 477, 1969.
43.
Coleman, E.N. : Infantile hypercalcaemia and cardiovascular lesions; evidence, hypothesis, and speculation. Arch. Dis. Child.40: 535, 1965.
44.
Bransby, E.R. , Berry, W.T.C. and Taylor, D.M.: Study of the vitamin-D intakes of infants in 1960. Brit. Med. J.1: 1661, 1964.
